Prevalence infections and risk factors due to HIV, hepatitis B and C: In a prison establishment in Leiria;Prevalência e factores de risco das infecções por VIH, hepatite B e C: Num estabelecimento prisional de Leiria

Acta Medica Portuguesa

Volumn 17, Issue 5, 2004, Pages 381-384

  Passadouro, Rui ^a  

^a Ministerio da Saude Portuguese   (Portugal)

Author keywords

Epidemiology; Hepatitis B; Hepatitis C; HIV infections; Prisons

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; DRUG ABUSE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PREVALENCE; PRISON; QUESTIONNAIRE; RISK FACTOR; SEXUAL BEHAVIOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PORTUGAL; PREVALENCE; PRISONS; RISK FACTORS;

EID: 14644396108     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. TORRES AC, GOMES MC: Drogas e prisões em Portugal. CIES/ISCTE, Lisboa 2002
2. FERREIRA, MOS: A infecção pelo VIH nas prisões. Prisões em Revista 1996; 0: 14-5
3. FRANCO F, GOMES C, OLIVEIRA R: IV jornadas médicas dos serviços prisionais. Prisotild;es em Revista 2002; 20: 23
4. DUFOUR A, ALARY M, POULIN C et al: Prevalence and risk for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996; 10:1009-15.
5. PEREIRA AP, COSTA LG: Nos limites do social - droga e meio prisional. Temas penitenciários (Direcção Geral dos Serviços Prisionais) 1989; 2: 19-25
6. PROVEDOR DE JUSTIÇA: Relatório sobre o sistema prisional 2003. [Em linha] Disponível em http://www.provedor-jus.pt/publicacoes/ Rel2003Prisoes/welcome.html [Consultado em 30/11/2003].
7. THORTON L, BARRY J, ALLWRIGHT S, BRADLEY F, PARRY JV: Comparison between self-reported hepatites b, Hepatitis c, and HIV antibody status and oral fluid assay in Irish prisoners. Commun Dis Public Health 2000; 3(4):253-5
8. ROTILY M, VAISSE, V, BOURLIÉRE M, PUJOL AG, ROUSSEAU S, OBADIA Y: HVB and HIV screening, and hepatitis B immunization programme in the prison of Marseille, France. Int J STD AIDS 1997; 12: 753-9
9. GRIFFIN MM, RYAN JG, BRISCOSE VS, SHADLE KM: Effects of incarceration on HIV-infected individuals. J Natl Med Assoc 1996; 88; 10: 639-44
10. SANCHEZ VM, BUQUERAS J, MORIS ML, ALONSO LE, PÉREZ RV: Evaluation of the prevalence of HIV infection in prison inmates at the time of their imprisonment during the period 1991-1995. Ver Esp Salud Publica 1997; 71; 3: 269-80
11. Grupo Castellano-Leones Para el Estudio de Infeccion VIH en Prisiones: Study of cases of HIV infection in Castile-Leon prisons. Rev Clin Esp 2001; 201(5): 249-55
12. PASSADOURO R, MENDES O, PINTO H: Prevalência das infecções por HIV, Hepatite B e C num estabelecimento prisional de Leiria. Rev Port Doenc Infec 1998; 21(4): 176-8
13. SANTOS A, CRVALHO A, TOMAZ J et al: Prevalência dos marcadores de infecção pelo vírus da hepatite B na população adulta do distrito de Coimbra. Acta Med Port 2000; 13: 167-171
14. SANTOS A, CRVALHO A, TOMAZ J et al: A epidemiologia da hepatite C na região Centro de Portugal: prevalência do anti-VHC no distrito de Coimbra. Acta Med Port 1993; 6: 567-572
15. ROBERT F, ANDA MS, SCOTT B et al: Hepatitis B in Wisconsin Male Prisoners: Considerations for serologic screening na vaccination. AJPH 1985; 75; 10: 1182-5.
16. BUTLER TG, DOLAN KA, FERSON MJ, MCGUINESS LM, BROWN PR, ROBERTSON PW: Hepatitis B and C in New South Wales prisons: prevalence and risk factores. Med J Aust 1997; 166; 3: 127-30
17. MAUSNER & BAHN: Introdução à Epidemiologia. Fundação Calouste Gulbenkian. Lisboa, 1990.
18. a Edition, London, 1994.
19. PALLAS JR, FARINAS-ALVAREZ C, PRIETO D et al: Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur J Epidemiol 1999; 15(8):699-704